Cambrex

Cambrex is a small molecule company that offers drug substance, drug product, and analytical services. The company provides an end-to-end partnership for the research, development, and manufacture of small molecule therapeutics at every stage of the lifecycle. With years of experience and a growing team of experts servicing global clients, the company is tried and trusted in branded and generic markets for API and dosage form development and manufacturing. It was founded on 1981 and is headquartered in East Rutherford, New Jersey.

4 past transactions

Avista Pharma

Acquisition in 2018
Avista Pharma Solutions is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of scientifically-differentiated services ranging from early drug development to drug product manufacturing.

Halo Pharmaceutical

Acquisition in 2018
Halo Pharma based in Whippany, New Jersey, is a leading provider of contract dosage form development, manufacturing, and testing services to the pharmaceutical, biotechnology, and generic industries. Like our customers, we are passionate about making a difference in the lives of patients.

PharmaCore

Acquisition in 2016
PharmaCore is a leading partner in small molecule drug discovery, development and manufacturing for pharmaceutical and biotechnology companies. The PharmaCore offering parallels the drug discovery process and provides significant advantages at each step from lead discovery to lead optimization, chemical synthesis and scale-up of pharmaceutical intermediates as well as chemical process R&D. PharmaCore is an industry leader in custom organic synthesis using diverse chemistries to produce active pharmaceutical ingredients and scaffolds. PharmaCore has GMP manufacturing facilities for scale-up of pharmaceutical APIs in gram to multi-kilogram quantities. These facilities include eight GMP production areas with reactors to 2000 liters. In support of our GMP manufacturing, PharmaCore’s experienced Quality Assurance department assures compliance with current FDA and international regulations. At PharmaCore, we are equipped to provide non GMP and GMP API manufacture from grams to 100’s of kilograms. PharmaCore has a state-of-the-art cGMP analytical services laboratories. Offering a diverse range of analytical testing capabilities and experienced methods development and validation services, as well as years of industry-proven expertise, PharmaCore can meet your analytical needs, big or small, long-range or short. At PharmaCore we are licensed to manufacture controlled substances in schedules 2-5. We have experience in the logistics management of these regulated materials under licenses that include Analytical, Research and Manufacturing. Many of our clients utilize PharmaCore’s highly experienced scientists as an extension of their own chemistry team by way of short and long term contract research programs.

Xcellsyz

Acquisition in 2006
Xcellsyz is a biotechnology company, focusses on the discovery of new drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.